“…During the last decades, a variety of therapeutic approaches and interventions have been proposed to manage poor responsiveness to in vitro fertilization techniques, including uterine interventions [ 48 , 49 , 50 , 51 , 52 ], gynecological surgical procedures [ 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ], immunomodulatory therapies [ 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 ] or treatments to enhance endometrial receptivity [ 69 , 70 , 71 , 72 , 73 ]. However, it was not until 2015 [ 8 ] that autologous platelet concentrates were used to promote endometrial growth and improve pregnancy outcome in infertile women with TE.…”